Aptinyx Incis A Clinical Stage Biopharmaceutical Company Based In Evanstonillinoisfounded In 2015The Company Is Dedicated To Discovering And Developing Innovative Therapies For Disorders Of The Brain And Nervous Systemaptinyx Specializes In Creating Proprietary Small Molecules That Modulate N Methyl D Aspartatenmdareceptorsaiming To Enhance Synaptic Plasticity And Improve Neural Communication The Company S Key Product Candidatenyx 783Is Currently In Phase I Clinical Trials For Treating Opioid Use Disorder And Is Also Being Explored For Alcohol Use Disorderaptinyx Has A Strong Preclinical Pipeline That Includes Various Candidates Targeting Cognitive Impairment And Post Traumatic Stress Disorderptsd The Company Collaborates With Allergan Plc To Advance Its Therapeutic Offeringsreflecting Its Commitment To Addressing Significant Unmet Medical Needs In Central Nervous System Disorders
No conferences found for this company.
| Company Name | Aptinyx Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
